The official Twitter for Novartis-sponsored clinical trials currently recruiting in the US only. See our community guidelines: https://xitter.cf/t.co/fZJuthJmCT
The phase 2/3 EPIK-L1 trial is now recruiting patients with #LymphaticMalformations. See if your patient is eligible.
Learn more: medinfo.novartispharmaceutic…
This is intended for US health care professionals.
The phase 3b Adjuvant WIDER trial is now enrolling. Help identify eligible patients with HR+/HER2– #EarlyBreastCancer. Learn more: medinfo.novartispharmaceutic…
This is intended for US health care professionals.